Allopurinol as a therapeutic option in cardiovascular disease

Osita N Okafor, K Farrington, Diana A Gorog

Research output: Contribution to journalReview articlepeer-review

43 Citations (Scopus)


Epidemiological studies indicate that hyperuricaemia is an independent risk factor for cardiovascular disease. Alongside uric acid formation, increased xanthine oxidase activity also results in the formation of oxidative free radicals and superoxide particles. Oxidative stress significantly contributes to the development of cardiovascular disease, including endothelial cell dysfunction, atherosclerosis, vascular calcification and impaired myocardial energetics. Allopurinol, a competitive xanthine oxidase inhibitor, in addition to reducing serum uric acid levels, can act as a free radical scavenger. Although traditionally used for the management of gout, there has been renewed interest in the role of allopurinol in the management of cardiovascular disease. In this review, we summarise the role of the xanthine oxidase pathway in the generation of oxidative stress and evaluate the current body of evidence assessing the clinical effects of allopurinol in patients with cardiovascular disease. A number of small clinical studies have shown a beneficial effect of allopurinol in reducing ischemia-reperfusion injury in the setting of bypass surgery and coronary angioplasty. Additionally, studies in heart failure indicate a potential favourable effect of allopurinol on endothelial dysfunction, LV function and haemodynamic indices, particularly in those with raised serum uric acid levels. Whilst this cheap and readily available pharmacological option may offer a very cost effective therapeutic option, large-scale prospective studies are required to better delineate its role in reducing hard clinical end-points.
Original languageEnglish
Pages (from-to)139-150
Number of pages12
JournalPharmacology & Therapeutics
Early online date2 Dec 2016
Publication statusPublished - 1 Apr 2017


  • Allopurinol
  • Animals
  • Cardiovascular Diseases
  • Enzyme Inhibitors
  • Free Radical Scavengers
  • Humans
  • Hyperuricemia
  • Myocardial Reperfusion Injury
  • Oxidative Stress
  • Risk Factors
  • Uric Acid
  • Xanthine Oxidase
  • Journal Article
  • Review


Dive into the research topics of 'Allopurinol as a therapeutic option in cardiovascular disease'. Together they form a unique fingerprint.

Cite this